Archive Newsletter

  1. 03.26.24 -- What Proposed Plasmid DNA Standards Say For GMP/Non-GMP Production 3/26/2024
    03/26/24 Clinical Supply Leader Newsletter
  2. 03.19.24 -- Unique Challenges Of Clinical Supply For EAPs And ISTs 3/19/2024
    03/19/24 Clinical Supply Leader Newsletter
  3. 03.12.24 -- Novartis CAR-T Trials Highlight Complicated Clinical Supply Chain 3/12/2024
    03/12/24 Clinical Supply Leader Newsletter
  4. 03.05.24 -- Does Your Post-Pandemic Planning Include Direct-To-Patient Deliveries? 3/5/2024
    03/05/24 Clinical Supply Leader Newsletter
  5. Best of February: Top 5 Insights In Clinical Supply Chain & Logistics 2/28/2024
  6. 02.27.24 -- Clinical Manufacturing Case Study Focused On Raw Materials 2/27/2024
    02/27/24 Clinical Supply Leader Newsletter
  7. 02.20.24 -- How To Properly Evaluate Suppliers, Including Potential Risk 2/20/2024
    02/20/24 Clinical Supply Leader Newsletter
  8. 02.13.24 -- How Does Continuous Manufacturing Impact Clinical Supply? 2/13/2024
    02/13/24 Clinical Supply Leader Newsletter
  9. 02.06.24 -- Donating Surplus Trial Supplies Is Sustainability's 'Low-Hanging Fruit' 2/6/2024
    02/06/24 Clinical Supply Leader Newsletter
  10. Best of January: Top 5 Insights In Clinical Supply Chain & Logistics 1/31/2024